Bioventix - BVXP Share Forecast, Price & News

Bioventix's stock was trading at GBX 3,990 at the start of the year. Since then, BVXP shares have increased by 0.8% and is now trading at GBX 4,020.
View the best growth stocks for 2023 here.

Bioventix PLC (LON:BVXP) announced its quarterly earnings results on Monday, March, 30th. The biotechnology company reported $69.28 EPS for the quarter. Bioventix had a trailing twelve-month return on equity of 64.92% and a net margin of 65.48%.

Bioventix declared a dividend on Monday, March 27th. Stockholders of record on Thursday, April 6th will be given a dividend of GBX 62 per share on Friday, April 21st. This represents a yield of 1.62%. The ex-dividend date is Thursday, April 6th. The official announcement can be accessed at this link.
Read our dividend analysis for BVXP.

Bioventix (LON:BVXP) pays an annual dividend of GBX 126 per share and currently has a dividend yield of 3.33%. The dividend payout ratio is 8,630.14%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for BVXP.

Based on aggregate information from My MarketBeat watchlists, some companies that other Bioventix investors own include Lancashire (LRE), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Entain PLC (GVC.L) (GVC), Arbutus Biopharma (ABUS), Aurora Cannabis (ACBFF), AcelRx Pharmaceuticals (ACRX), Aldeyra Therapeutics (ALDX), Ampio Pharmaceuticals (AMPE) and Apellis Pharmaceuticals (APLS).

Bioventix trades on the London Stock Exchange (LON) under the ticker symbol "BVXP."

Shares of BVXP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of BVXP stock can currently be purchased for approximately GBX 4,020.

Bioventix (LON:BVXP) has a market capitalization of £209.84 million and generates £11.72 million in revenue each year. The biotechnology company earns £7.67 million in net income (profit) each year or GBX 1.46 on an earnings per share basis.

Bioventix's mailing address is 7 Romans Business Park, East Street, FARNHAM, GU9 7SX, United Kingdom. The official website for the company is www.bioventix.com. The biotechnology company can be reached via phone at +44-1252-728001.